How do you find using the New Zealand Gazette? Please give your feedback by completing this survey.

Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

Product: Faslodex
Active Ingredient: Fulvestrant 50mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: AstraZeneca Limited
Manufacturer: Vetter Pharma-Fertigung GmbH & Co KG, Ravensburg, Germany
Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany
   
Product: Fluzone High-Dose
Active Ingredients: Influenza virus A/Michigan/45/2015 (H1N1) pdm09 - like strain 60mcg
Influenza virus A/Singapore/INFIMH-16-0019/2016 (H3N2) - like strain 60mcg
Influenza virus B/Phuket/3073/2013 - like strain 60mcg
Dosage Form: Suspension for injection
New Zealand Sponsor: Sanofi-aventis New Zealand Limited
Manufacturer: Sanofi Pasteur Inc, Pennsylvania, United States of America

Dated this 15th day of July 2020.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on the 11 September 2013).